Published in J Clin Oncol on January 01, 1990
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys (2014) 3.69
Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer (1998) 1.32
MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol (2003) 1.30
Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer (2001) 1.15
Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg (2004) 1.15
Correlation between mammographic and sonographic findings and prognostic factors in patients with node-negative invasive breast cancer. Br J Radiol (2010) 1.07
Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92. J Epidemiol Community Health (1996) 1.07
Management of screen-detected breast cancer: audit of the first 100 cases in the Southampton and Salisbury breast screening programme. Ann R Coll Surg Engl (1993) 1.05
Pregnancy and breast cancer: a population-based study. Virchows Arch (2003) 0.96
Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients. Eur Radiol (2005) 0.92
Pathologic Assessment of Surgical Margins on Frozen and Permanent Sections in Breast Conserving Surgery. Breast Cancer (1995) 0.91
Re-excision Rates and Local Recurrence in Breast Cancer Patients Undergoing Breast Conserving Therapy. Geburtshilfe Frauenheilkd (2012) 0.90
Current management of carcinoma of the breast. Ann Surg (1994) 0.87
Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence. World J Surg (2007) 0.86
Magnetic resonance imaging in size assessment of invasive breast carcinoma with an extensive intraductal component. BMC Med Imaging (2009) 0.86
A review of current practices in breast conservation surgery in the UK. Ann R Coll Surg Engl (2007) 0.82
The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg (1991) 0.82
Imaging-assisted large-format breast pathology: program rationale and development in a nonprofit health system in the United States. Int J Breast Cancer (2012) 0.82
Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current Evidence. Breast Care (Basel) (2015) 0.81
Comparison of mammography and ultrasound in detecting residual disease following bioptic lumpectomy in breast cancer patients. Mol Clin Oncol (2016) 0.81
Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center. Ann Surg Oncol (2016) 0.81
Margins! Margins. Margins? How Important Is Margin Status in Breast-Preserving Therapy? Breast Care (Basel) (2011) 0.80
Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier. Exp Hematol Oncol (2012) 0.80
Correlation between conductivity and prognostic factors in invasive breast cancer using magnetic resonance electric properties tomography (MREPT). Eur Radiol (2015) 0.79
Accelerated partial breast irradiation with brachytherapy: patient selection and technique considerations. Breast Cancer (Dove Med Press) (2015) 0.78
Assessment of Practice Patterns Following Publication of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer. Ann Surg Oncol (2015) 0.78
Radiation therapy in early-stage invasive breast cancer. Indian J Surg Oncol (2011) 0.77
Breast conservation for mammographically occult carcinoma. Ann Surg (1998) 0.77
The effect of simultaneous peripheral excision in breast conservation upon margin status. Ann Surg Oncol (2010) 0.76
Impact of an extensive in situ component on the presence of residual disease in screen detected breast cancer. J R Soc Med (1991) 0.76
Higher Level of P-glycoprotein Expression in Human Breast Cancer Cells after Radiation Therapy. Breast Cancer (1995) 0.76
Radiobiological characterization of post-lumpectomy focal brachytherapy with lipid nanoparticle-carried radionuclides. Phys Med Biol (2011) 0.76
Enhancing area surrounding breast carcinoma on MR mammography: comparison with pathological examination. Eur Radiol (2004) 0.75
[Oncoplastie with breast conservation in breast cancer treatment: about 16 cases]. Pan Afr Med J (2015) 0.75
Comparison of Local Recurrence After Simple and Skin-Sparing Mastectomy Performed in Patients with Ductal Carcinoma In Situ. Ann Surg Oncol (2016) 0.75
Intraoperative radiotherapy as a protocol for the treatment of initial breast cancer. Einstein (Sao Paulo) (2013) 0.75
Management of ductal carcinoma in situ of the breast. Ann R Coll Surg Engl (1995) 0.75
General surgery. Postgrad Med J (1991) 0.75
DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy. Br J Cancer (1991) 0.75
Appropriate margin for lumpectomy excision of invasive breast cancer. Chin Clin Oncol (2016) 0.75
Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet institute. Int J Breast Cancer (2014) 0.75
Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers. Breast Cancer (Auckl) (2015) 0.75
A Transistor-like pH Nanoprobe for Tumour Detection and Image-guided Surgery. Nat Biomed Eng (2016) 0.75
Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet (1984) 10.22
Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med (2001) 7.47
Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. Am J Prev Med (2000) 6.43
Prostitution and risk of HIV: female prostitutes in London. BMJ (1993) 6.06
The body-mass index of twins who have been reared apart. N Engl J Med (1990) 5.11
Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ (1991) 4.67
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67
Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet (1990) 4.62
Junction adhesion molecule is a receptor for reovirus. Cell (2001) 4.00
Does rectal gonorrhoea reflect unsafe sex? Lancet (1991) 3.99
Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. BMJ (1991) 3.98
Prostitute women and public health. BMJ (1988) 3.76
Priorities among recommended clinical preventive services. Am J Prev Med (2001) 3.70
Preverbal and verbal counting and computation. Cognition (1992) 3.61
Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer (1985) 3.60
Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst (1996) 3.45
Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol (1992) 3.39
A prospective study of benign breast disease and the risk of breast cancer. JAMA (1992) 3.29
A three-item scale for the early prediction of stroke recovery. Lancet (2001) 3.15
Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol (1999) 3.04
Smallest real difference, a link between reproducibility and responsiveness. Qual Life Res (2001) 2.97
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol (1995) 2.96
High-molecular-weight plasmid correlates with Escherichia coli enteroinvasiveness. Infect Immun (1982) 2.95
Intracranial germ-cell tumors: natural history and pathogenesis. J Neurosurg (1985) 2.93
Sonographic identification of second-trimester fetuses with Down's syndrome. N Engl J Med (1987) 2.89
The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers. Cancer (1993) 2.88
Field trial of oral cholera vaccines in Bangladesh. Lancet (1986) 2.85
Candida albicans resistance in AIDS. J Infect (1991) 2.78
Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys (1992) 2.78
Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry (1993) 2.77
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol (1994) 2.77
The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med (1996) 2.74
Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet (1996) 2.67
[The treatment of ductal carcinoma in situ (DCIS) of the breast]. Ned Tijdschr Geneeskd (2003) 2.67
Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis (1988) 2.57
Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res (1999) 2.55
Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol (1998) 2.53
HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement. Am J Clin Pathol (2000) 2.53
HTLV-III: should testing ever be routine? Br Med J (Clin Res Ed) (1986) 2.51
Radiation therapy of early carcinoma of the breast without mastectomy. Cancer (1980) 2.49
Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med (1999) 2.45
Variability signatures distinguish verbal from nonverbal counting for both large and small numbers. Psychon Bull Rev (2001) 2.41
Studies of cellular immunity in male homosexuals in London. Lancet (1983) 2.41
Headache rate and cost of care following lumbar puncture at a single tertiary care hospital. Neurology (2011) 2.40
The complete set of predicted genes from Saccharomyces cerevisiae in a readily usable form. Genome Res (1997) 2.31
Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party. J Pathol (1997) 2.28
Rape and subsequent seroconversion to HIV. BMJ (1989) 2.26
The relationship between shaved margin and inked margin status in breast excision specimens. Cancer (1997) 2.22
Improved methodology for analyzing local and distant recurrence. J Clin Oncol (1990) 2.21
Methods for systematic reviews of economic evaluations for the Guide to Community Preventive Services. Task Force on Community Preventive Services. Am J Prev Med (2000) 2.20
Numerical abstraction by human infants. Cognition (1990) 2.20
Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening. J Biol Chem (2000) 2.12
Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys (1979) 2.10
The contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancer. Cancer (1991) 2.10
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol (1992) 2.05
Methods for priority setting among clinical preventive services. Am J Prev Med (2001) 2.05
Three-year prospective study of HTLV-III/LAV infection in homosexual men. Lancet (1986) 2.04
Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes. J Psychiatry Neurosci (1993) 2.02
To boost or not to boost, and how to do it. Int J Radiat Oncol Biol Phys (1991) 2.02
Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands. Soc Sci Med (2000) 2.01
Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies. Circulation (1986) 2.00
p53 antigen loss in stored paraffin slides. N Engl J Med (1995) 1.99
Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer (1991) 1.97
A model for breast cancer screening. Cancer (1990) 1.96
Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet (1990) 1.96
Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer (1984) 1.95
The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer (1989) 1.94
Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology (1995) 1.93
Local impact of the NHMRC early breast cancer guidelines: where to from here? Med J Aust (1997) 1.93
Frequency and predictors of axillary lymph node metastases in invasive breast cancer. ANZ J Surg (2001) 1.93
Randomised controlled trial of hydroquinine in muscle cramps. Lancet (1997) 1.89
Sexually transmitted diseases in homosexual relationships. J Ir Med Assoc (1972) 1.89
Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol (2000) 1.89